3 Stocks That Are Giving Their Investors Coal in Their Stockings,

Zuranolone, Sage’s drug that helps treat depression, failed a phase 3 trial in … fell nearly 60% in a day after the drug once again failed a clinical trial., Zuranolone, Sage’s drug that helps treat depression, failed a phase 3 trial in … fell nearly 60% in a day after the drug once again failed a clinical trial., Read More

Scroll to Top